NF-2208
N/A
Report date: 2024/08/21 16:52:06
Base Information
Drug NameNF-2208
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShenzhen Taili Biomedicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShenzhen Xinyang Weikang Technology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A